Role of pregnane x receptor activation on macrophage function and diabetic wound healing

孕烷X受体激活对巨噬细胞功能和糖尿病伤口愈合的作用

基本信息

  • 批准号:
    10730438
  • 负责人:
  • 金额:
    $ 43.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary: While there are a significant number of co-morbidities associated with type 1 and type 2 diabetes (T1D and T2D), one of the more prevalent and severe sequalae of diabetes is diabetic foot ulceration (DFU) with approximately 25% of diabetics developing DFU in their lifetime. Out of all diabetics with DFU, approximately 15-20% of these cases will result in limb amputation due to incomplete healing. Under normal conditions, wound healing is a finely tuned, orchestrated effort by a host of cell types. Amongst these cell types, macrophage function, specifically macrophage plasticity, has been shown to play a critical role in normal wound healing. Thus, alterations in macrophage plasticity and/or function may have a detrimental effect on wound healing. Recent studies have shown that exposure to environmental contaminants, such as organochlorine pesticide metabolites and polychlorinated biphenyls among others, can alter macrophage function. However, the mechanisms governing environmental exposure and other xenobiotic related alterations in macrophage function remain elusive. One potential mechanism governing these exposures is activation of the pregnane x receptor (PXR). The PXR has been widely studied for its role in xenobiotic metabolism due to high levels of expression in the intestines and the liver as well as its ability to bind and become activated by a diverse set of ligands, including commonly used therapeutics and a wide array of environmental contaminants. Thus, the overall hypothesis of this application is that activation of the PXR decreases macrophage plasticity via decreased pro-inflammatory polarization with a corresponding decrease in bactericidal efficacy which will have a deleterious effect on pressure-induced wound healing. We will test this hypothesis in the following three specific aims. In aim 1, we will determine the role of the PXR in macrophage polarization and phagocytic/bactericidal activity in primary macrophages isolated from wild type and PXR knock out (KO) mice under normo- and hyperglycemic conditions. In aim 2 we will determine the effects of PXR activation on pressure-induced wound healing kinetics in both normal and streptozotocin (STZ)-induced diabetic wild type and PXR KO mice. Lastly in aim 3 we will evaluate the ability of the PXR to augment the pathogenicity of clinically relevant diabetic foot ulcer S. aureus isolates. Successful completion of these studies will further delineate the role of the PXR in macrophage function as well as determine if augmentation of PXR function may be deleterious to healing of S. aureus-infected pressure wounds, which is critical given increased S. aureus colonization is positively associated with non-healing DFUs. If PXR plays a deleterious role in wound healing, xenobiotics which activate PXR could be identified as a risk factor for non-healing DFUs to tailor therapeutic regimens in a patient specific manner.
项目总结:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

George E Howell其他文献

George E Howell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('George E Howell', 18)}}的其他基金

Organochlorine compound-induced alterations in adipocyte/macrophage crosstalk and effects on wound healing
有机氯化合物诱导脂肪细胞/巨噬细胞串扰的改变及其对伤口愈合的影响
  • 批准号:
    9808093
  • 财政年份:
    2019
  • 资助金额:
    $ 43.95万
  • 项目类别:
Organochlorine compound-induced alterations in adipocyte/macrophage crosstalk and effects on wound healing
有机氯化合物诱导脂肪细胞/巨噬细胞串扰的改变及其对伤口愈合的影响
  • 批准号:
    10011821
  • 财政年份:
    2019
  • 资助金额:
    $ 43.95万
  • 项目类别:
Effects of organochlorine pesticide exposure on hepatic lipid metabolism in type 2 diabetes
有机氯农药暴露对2型糖尿病肝脂代谢的影响
  • 批准号:
    9098998
  • 财政年份:
    2016
  • 资助金额:
    $ 43.95万
  • 项目类别:
Effect of exposure to organochlorine compounds on the development of obesity and
接触有机氯化合物对肥胖和肥胖发展的影响
  • 批准号:
    7960792
  • 财政年份:
    2010
  • 资助金额:
    $ 43.95万
  • 项目类别:
The role of exposure to bioaccumulative organochlorine compounds on the occurrenc
接触生物累积性有机氯化合物对发生的作用
  • 批准号:
    8726530
  • 财政年份:
    2010
  • 资助金额:
    $ 43.95万
  • 项目类别:
The role of exposure to bioaccumulative organochlorine compounds on the occurrenc
接触生物累积性有机氯化合物对发生的作用
  • 批准号:
    8307582
  • 财政年份:
    2010
  • 资助金额:
    $ 43.95万
  • 项目类别:
Effect of exposure to organochlorine compounds on the development of obesity and
接触有机氯化合物对肥胖和肥胖发展的影响
  • 批准号:
    8145554
  • 财政年份:
    2010
  • 资助金额:
    $ 43.95万
  • 项目类别:
The role of exposure to bioaccumulative organochlorine compounds on the occurrenc
接触生物累积性有机氯化合物对发生的作用
  • 批准号:
    8036614
  • 财政年份:
    2010
  • 资助金额:
    $ 43.95万
  • 项目类别:
Transcriptional Regulation of SREBP-1c by Dietary Polyunsaturated Fatty Acids
膳食多不饱和脂肪酸对 SREBP-1c 的转录调节
  • 批准号:
    7615186
  • 财政年份:
    2009
  • 资助金额:
    $ 43.95万
  • 项目类别:

相似海外基金

New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
  • 批准号:
    1654774
  • 财政年份:
    2015
  • 资助金额:
    $ 43.95万
  • 项目类别:
    Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8416313
  • 财政年份:
    2012
  • 资助金额:
    $ 43.95万
  • 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8298885
  • 财政年份:
    2012
  • 资助金额:
    $ 43.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了